Connect with us

Hi, what are you looking for?

Age-Related Macular Degeneration Market Size, Opportunities, Trends, Products, Revenue Analysis Till 2027

The age-related macular degeneration market is soaring higher all across the globe in recent times. So, the market value is predicted to reach USD 11.18 billion during the forecast period.

Market Dynamics

Over the years, drug manufacturers worldwide have developed patent-expired branded medicines for the treatment of this condition, resulting in an increase in demand. Due to the growing geriatric population and the prevalence of numerous cases of the condition, the market potential is increasing. All of these factors contribute to the growth of the age-related macular degeneration market.

Permanent vision loss deteriorates over time and is a major concern for people in their senior years. The process of wearing down the macula and resulting in the condition is classified as dry or wet. Both forms are dangerous and require medication. The growing demand for treatment among the senior population expands the potential market for age-related macular degeneration.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/5736

Segmental Analysis

The global market for age-related macular degeneration is segmented on the basis of stage, type, administration, treatment, age group, and end user.

The market for age-related macular degeneration is segmented into early-stage AMD, intermediate-stage AMD, and late-stage AMD in this segment. The intermediate stage of age-related macular degeneration is the most prevalent stage of AMD, accounting for the majority of cases.

The age-related macular degeneration market is segmented by type into wet and dry age-related macular degeneration. Wet AMD will experience the fastest growth, as it accounts for the majority of acute blindness.

This market segmentation for age-related macular degeneration includes both intravenous and intravitreal administration. The most popular route of administration is intravitreal, which accounts for the majority of market share. It is expected to expand at a rate of 7.7 percent.

The market for treatment encompasses both diagnosis and treatment. Due to high demand, the treatment segment will account for the largest share of the market.

The market is segmented into those over the age of 75, those over the age of 60, and those over the age of 40. Individuals over the age of 75 will experience the greatest growth of all.

This segment includes hospitals and clinics, as well as academic research institutes and diagnostic centers. Due to the rapid increase in treatment needs, the hospitals and clinics segment will command a sizable market share and grow at a 7.6 percent annual rate.

Regional Overview

The global market for age-related macular degeneration is analyzed across multiple regions, including the Americas, Asia-Pacific, Europe, the Middle East, and Africa.

Due to an aging population and an increase in ophthalmological disorders, the Americas will dominate the global age-related macular degeneration industry share.

Europe will hold the second-largest market share, owing to growing government initiatives and an expansion of the healthcare system.

Increased healthcare spending, an increase in the number of cases of eye disorders, and the growth of MNCs will all contribute to the age-related macular degeneration industry’s growth in the Asia Pacific region over the forecast period.

Competitive Dynamics

The notable players of the market are Novartis AG, Pfizer Inc, F. Hoffmann-La Roche AG, Acucela Inc., Ophthotech Corporation, GlaxoSmithKline PLC, Bayer AG, Rxi Pharmaceuticals, Inc., Regeneron Pharmaceutical Inc., Alimera Sciences Inc., Santen Pharmaceuticals Co., ALLERGAN, and Bausch & Lomb Incorporate.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/age-related-macular-degeneration-market-5736

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Have a Look at Related Reports:

Dental CAD/CAM Market

Hazmat Suits Market

Musculoskeletal System Disorders Market

Telehealth Market

Implantable Cardioverter Defibrillator Market

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: [email protected]

You may also like:

World

Calling for urgent action is the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF)

Business

The cathedral is on track to reopen on December 8 - Copyright AFP Ludovic MARINParis’s Notre-Dame Cathedral, ravaged by fire in 2019, is on...

Business

Saudi Aramco President & CEO Amin Nasser speaks during the CERAWeek oil summit in Houston, Texas - Copyright AFP Mark FelixPointing to the still...

Business

Hyundai on Wednesday revealed plans to invest more than $50 billion in South Korea by 2026.